NCT03350789

Brief Summary

This research is planned to build a basis about the efficacy and mechanism of acupuncture on pain and emotional disorder in patients with chronic sciatica using fMRI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 22, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

April 9, 2018

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

April 19, 2018

Status Verified

April 1, 2018

Enrollment Period

2.7 years

First QC Date

November 15, 2017

Last Update Submit

April 17, 2018

Conditions

Keywords

acupuncturesciaticaMRI, functional

Outcome Measures

Primary Outcomes (1)

  • Visual analogue scale for bothersomeness

    change in visual analoge scale for bothersomeness \[range: 0(better)-100(worse) mm\]

    baseline, 1-1, 1-2, 2-1, 2-2, 3-1, 3-2, 4-1, 4-2, 5, and 8 weeks

Secondary Outcomes (8)

  • Visual analogue scale for pain intensity

    baseline, 1-1, 1-2, 2-1, 2-2, 3-1, 3-2, 4-1, 4-2, 5, and 8 weeks

  • Oswestry Disability Index

    week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  • EuroQol 5-Dimension

    week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  • Coping Strategy Questionnaire

    week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  • Beck Depression Inventory

    week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  • +3 more secondary outcomes

Study Arms (2)

Real acupuncture

EXPERIMENTAL

manual acupuncture + electroacupuncuture on acupoints, twice a week, for 4 weeks

Device: Real acupuncture

Sham acupuncture

SHAM COMPARATOR

sham acupuncture (no skin penetration) + placebo electroacupuncture without electrical stimulation on acupoints, twice a week, for 4 weeks

Device: Sham acupuncture

Interventions

manual acupuncture(0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) (unilateral GB30) + electroacupuncture(0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) (unilateral EX-B2 (L4 \& L5), BL25, BL23, BL40, GB34), twice a week, for 4 weeks, common approaches for the treatment of chronic sciatica used by doctors of Korean medicine in Korea today

Real acupuncture

sham acupuncture without skin penetration(0.25mm diameter x 40mm length, stainless steel, Acuprime, UK) (unilateral GB30) + placebo electroacupuncture (0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) without electrical stimulation (unilateral EX-B2, BL25, BL23, BL40, GB34), twice a week, for 4 weeks

Sham acupuncture

Eligibility Criteria

Age19 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults 19 years of age or more and 70 years of age or less
  • clinical diagnosis of chronic sciatica (pain lasting 3 months or more)
  • mm or more of 100mm VAS for bothersomeness due to sciatica
  • volunteers through announcements and advertisements with written informed consent

You may not qualify if:

  • spinal surgery within the past 6 months
  • diagnosis of specific severe diseases resulting in sciatica: malignant tumor, spinal infection, inflammatory sponlylitis
  • progressive neurological deficit or severe neurological signs
  • other chronic diseases which could disturb the effect of treatments and the results of the study: cardiovascular diseases, autoimmune diseases, renal diseases, diabetic neuropathy, dementia, epilepsy
  • inadequate or insafe for the treatment of acupuncture/ electroacupuncture: hemorrhagic diseases, medication of anticoagulant, serious diabetes mellitus vulnerable to infections, serious cardiovascular diseases/ pacemaker, metal materials interior of the body
  • currently or might be pregnant
  • severe mental illness
  • currently participating other clinical trials
  • experience of acupuncture or electroacupuncture treatment, or taking medicines which might affect the symptom of pain such as corticosteroids, narcotics, NSAIDs or considered to be inadequate by the investigators within the past week (But they could be included only after going through 2 weeks of wash out period.)
  • difficulty of writing informed consent
  • inadeguate or insafe for MRI scanning: claustrophobia, metal materials interor of the body
  • other inadequate subjects assessed by the study investigators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyung Hee University Hospital at Gangdong

Seoul, 05278, South Korea

RECRUITING

Related Publications (1)

  • Kim KW, Park K, Park HJ, Jahng GH, Jo DJ, Cho JH, Song EM, Shin WC, Yoon YJ, Kim SJ, Eun S, Song MY. Effect and neurophysiological mechanism of acupuncture in patients with chronic sciatica: protocol for a randomized, patient-assessor blind, sham-controlled clinical trial. Trials. 2019 Jan 16;20(1):56. doi: 10.1186/s13063-018-3164-8.

MeSH Terms

Conditions

Sciatica

Condition Hierarchy (Ancestors)

Sciatic NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeuralgiaPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mi-Yeon Song, Ph.D.

    Department of Rehabilitation Medicine of Korean Medicine, Kyung Hee University Hospital at Gangdong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Koh-Woon Kim, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, K.M.D., Ph.D.

Study Record Dates

First Submitted

November 15, 2017

First Posted

November 22, 2017

Study Start

April 9, 2018

Primary Completion

January 1, 2021

Study Completion

February 1, 2021

Last Updated

April 19, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations